Puma Biotech (NASDAQ: PBYI) reported Q1 EPS of $0.10. Revenue for the quarter came in at $46 million versus the consensus estimate of $47.5 million.

GUIDANCE:

Puma Biotech sees Q2 2025 revenue of $48-50 million, versus the consensus of $52.75 million.

Puma Biotech sees FY2025 revenue of $192-198 million, versus the consensus of $218.2 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.